What SHA means for your pharmacy, and why you cannot claim from it

If you run a private retail pharmacy in Kenya and you have been waiting for the Social Health Authority to open up to you, this is the part nobody says plainly: it has not, and the current contracts make that clearer than ever. Worse, a rule that took effect on 1 October 2026 is designed to shrink the referred prescription trade that many pharmacies quietly depend on.

This guide sets out what the SHA contracts actually say, where the money goes, and what it means for your pharmacy. Everything here comes from SHA's own published contract documents. Where something could not be verified, it says so.

First, the hard answer: a retail pharmacy cannot contract with SHA

A standalone community or retail pharmacy cannot be empanelled by SHA, cannot sign an SHA contract, and cannot claim from SHA. This is not a backlog or a delay. It falls out of the eligibility wording itself.

SHA's Primary Healthcare Fund contract (Part B1, clause 2.1.1) says the contract applies to a healthcare provider admitted by the Authority, "being a health facility at KEPH Level 2 or 3, or a Level 4 facility approved by the Authority for the delivery of primary healthcare services."

To be admitted, a provider must be listed on the Kenya Master Health Facility List with a valid facility identification number and a KEPH level assignment. The contract's own signature block asks for a KMPDC or Clinical Officers Council registration number and a facility FID number.

Now look at what your pharmacy actually is. It is licensed by the Pharmacy and Poisons Board as pharmaceutical premises. It carries no KEPH level, it is not registered with KMPDC or the Clinical Officers Council, and it does not appear on the Master Health Facility List. There is no box on that form your licence fits into.

SHA's published directory of contracted facilities reflects the same thing structurally. It lists providers by KEPH level, from Level 2 to Level 6, organised by ownership. There is no pharmacy or chemist category at all.

You may have seen blog posts describing an SHA "pharmacy provider category", or a quarterly limit for chronic medicines collected at community pharmacies. We could not corroborate any of that against SHA, the Ministry of Health, or any gazette notice. Treat those claims as unfounded unless SHA publishes something itself.

One clarification worth making, because it causes real confusion. SHA does cover refills of medicines for stable chronic conditions. That is a benefit delivered by the contracted facility, not a benefit a patient can carry into your shop.

The rule that changed on 1 October 2026

Here is the part that affects your revenue even though you are not in the scheme.

Outpatient medicines are paid for through the Primary Healthcare Fund, which does not reimburse per item. Facilities receive a global budget weighted capitation, distributed monthly according to their share of verified beneficiary visits. Medicines sit inside that payment as a ring-fenced pharmacy component.

Clause 7.2 of the current contract ties that component to how much the facility actually dispenses:

"The dispensing rate shall be applied only to the pharmacy component of the payment. Where the Healthcare Provider dispenses one hundred per cent (100%) of prescribed medicines it shall receive the full pharmacy component; where it dispenses a lower percentage it shall receive that percentage of the pharmacy component and the balance shall be deducted."

Clause 7.2.2 defines the dispensing rate simply as medicines dispensed divided by medicines prescribed, recorded in the approved system and monitored through the Digital Health Agency platform. Clause 7.1.2 obliges providers to dispense every medicine they prescribe.

Clause 7.3.3 then closes the obvious escape route. A stock-out does not entitle a facility to charge a beneficiary, to direct a beneficiary to go and buy the item, or to require a beneficiary to bring one.

SHA may also publish each facility's dispensing rate, and may abate up to 25 per cent of monthly capitation where a provider contravenes its obligations.

Why that matters to a pharmacy that is not in the scheme

Think about what used to happen. A patient visits a clinic, the clinic is out of two of the four items prescribed, and the patient walks down the road to your pharmacy and pays cash. For a lot of pharmacies sited near health facilities, that flow is not a small side income. It is a real share of the counter.

Under the current contract, the facility that sends that patient to you now loses money twice. Its dispensing rate falls, so it forfeits that proportion of its pharmacy component, and it has breached a contractual obligation it can be penalised for. The prohibited charges clause expressly bars a contracted facility from making "any direction to a Beneficiary to attend a private consulting room, pharmacy, laboratory or facility and pay there for a Service available under this Contract."

So the referred prescription is not drying up by accident. It is being engineered out deliberately, and the facility now has a direct financial reason to keep that patient inside its own dispensary.

The effect will be sharpest for pharmacies sited close to Level 2, 3 and 4 facilities that are on capitation. If that describes your location, this is a planning problem for the next twelve months rather than a distant policy story.

How this came about

The direction of travel has been public for over a year. In August 2025 the Health Cabinet Secretary framed it bluntly as no drugs on the shelves, no pay. In January 2026 the Ministry of Health began real-time tracking and rejected claims where medicines had not actually been issued, citing counties where the gap between patients treated and prescriptions dispensed was very wide. In July 2026 SHA published the graduated formula, though without an effective date at the time.

What is different now is that this is no longer an announcement. It is a clause in a signed contract, effective from 1 October 2026 and running to 30 June 2029. The signing window was extended to 14 October 2026.

For completeness: the Social Health Insurance Act has been through the courts more than once. In March 2026 the High Court held the fund itself constitutional while faulting aspects of the 2024 rollout, and a further petition was filed in May 2026. We found no evidence that the dispensing rule has been delayed, revised, or withdrawn, and no published response to it from the Pharmaceutical Society of Kenya or the Kenya Pharmaceutical Association.

What to actually do about it

Stop modelling SHA as a future revenue line. If your business plan, your bank, or your investor deck assumes SHA money arrives at some point, take it out. Plan on cash, private insurance, and employer schemes.

Work out how exposed you really are. Look at your last three months and estimate what share of your prescription revenue walks in from a nearby public or contracted facility. If you cannot answer that from your records, that itself is the first thing to fix. You cannot manage a risk you cannot size.

Compete where SHA does not reach. Non-SHA walk-ins, over-the-counter trade, branded and non-formulary products, cosmetics, devices, diagnostics, adherence support for chronic patients, delivery, and longer opening hours are all outside the capitated flow. The pharmacies that handle this transition well will be the ones that had already stopped relying on the overflow from somebody else's stock-outs.

Consider the facility route only with clear eyes. If SHA revenue is genuinely strategic for you, the only door is to operate a Level 2 or 3 facility, licensed by KMPDC or the Clinical Officers Council and listed on the Master Health Facility List. That is a different business with real capital, staffing, and governance obligations. It is not a rebrand of a pharmacy, and anyone telling you otherwise has not read the contract.

Watch for a genuine change in policy. No pharmacy provider category exists today. If one is ever created it will arrive through an SHA or Ministry of Health gazette notice, not through a WhatsApp forward.

What we could not verify

In the interest of being straight with you, these points could not be confirmed from a primary source and are deliberately left out above: SHA claim submission turnaround times for pharmacies, any official list of claim rejection reasons, the widely circulated prescription completion percentage that traces only to an aggregator site, and any SHA pilot to empanel community pharmacies.

---

This guide is based on SHA's published contract documents and official statements as at October 2026. Policy in this area has moved quickly and continues to be litigated. Confirm the current position with SHA or the Ministry of Health before making a commercial decision, and treat this as general guidance rather than legal advice.

If you want help sizing your exposure or rebuilding your revenue mix around this, book a consultation and we will work through your numbers with you.